Publications by authors named "F Fraioli"
Article Synopsis
- Biomarkers in psychiatry are essential for better diagnosis and management, and radionuclide imaging (PET and SPECT) shows potential for practical use, particularly in schizophrenia-spectrum disorders.
- A systematic review evaluated 56 longitudinal studies involving 1,329 patients, focusing on the impact of PET and SPECT imaging on diagnosis and treatment personalization.
- Key findings indicated that PET and SPECT can predict treatment responses and optimize dosages of antipsychotic medications, highlighting the need for more clinical trials to confirm these benefits.
Joint EANM/EANO/RANO/SNMMI practice guideline/procedure standards for diagnostics and therapy (theranostics) of meningiomas using radiolabeled somatostatin receptor ligands: version 1.0.
Eur J Nucl Med Mol Imaging
October 2024
Purpose: To provide practice guideline/procedure standards for diagnostics and therapy (theranostics) of meningiomas using radiolabeled somatostatin receptor (SSTR) ligands.
Methods: This joint practice guideline/procedure standard was collaboratively developed by the European Association of Nuclear Medicine (EANM), the Society of Nuclear Medicine and Molecular Imaging (SNMMI), the European Association of Neurooncology (EANO), and the PET task force of the Response Assessment in Neurooncology Working Group (PET/RANO).
Results: Positron emission tomography (PET) using somatostatin receptor (SSTR) ligands can detect meningioma tissue with high sensitivity and specificity and may provide clinically relevant information beyond that obtained from structural magnetic resonance imaging (MRI) or computed tomography (CT) imaging alone.